4 days Pharma Stock Roundup: FDA Approves SNY’s Dupixent for COPD & More Zacks
FDA approves Sanofi’s Dupixent for COPD. Eli Lilly is set to invest $4.5 billion to build a new manufacturing and research site in Indiana.
FDA approves Sanofi’s Dupixent for COPD. Eli Lilly is set to invest $4.5 billion to build a new manufacturing and research site in Indiana.